Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in CATX — Perspective Therapeutics, Inc.

CIK 886982 NEW YORK, NY
Back to CATX Full portfolio

Position in CATX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,909,795
+$731,423 QoQ
Shares Held
1,733,078
+39.6% QoQ
Ownership
1.52%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 130 holders
Holding Since
Sep 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CATX Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $6,918,649,500 across 99 Medical Devices names. CATX ranks #50 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 16,760,070 $1,520,808,749
2 SYK
Stryker Corp
 2,783,782 $876,445,924
3 BSX
Boston Scientific Corp
 16,954,342 $723,611,313
4 MDT
Medtronic plc
 9,012,210 $705,025,184
5 EW
Edwards Lifesciences Corp
 4,549,113 $411,512,760
6 STE
STERIS plc
 1,363,145 $287,037,441
7 GEHC
GE HealthCare Technologies Inc.
 4,446,565 $284,624,625
8 PEN
Penumbra Inc
 847,104 $267,473,087

All Filings in CATX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,909,795 1,733,078
2026-03-31 $5,178,372 1,241,816
2025-12-31 $439,551 159,837
2025-09-30 $678,144 197,710
2025-06-30 $936,016 272,098
2025-03-31 $645,004 302,819
2024-12-31 $2,880,308 902,918
2024-09-30 $5,989,917 448,683
2024-03-31 $2,375,848 1,996,511
2023-09-30 $3,610 13,373